Admedus Profile

USD 0.035  21.21%

Admedus Summary

Admedus Limited (AMEUF) is traded on OTC Market in USA. It is located in 301 Coronation Drive and employs 12 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 55.44 M. Admedus Limited has 254.8 M outstanding shares. ADMEDUS has accumulated about 6.1 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Admedus Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 0.2HorizonTargetOdds Above 0.2
89.67%30 days 0.20 10.24%
Based on normal probability distribution, the odds of Admedus to move above current price in 30 days from now is about 10.24% (This Admedus Limited probability density function shows the probability of Admedus Stock to fall within a particular range of prices over 30 days) .

Admedus Limited Risk Profiles

Key Fundamentals

Admedus Against Markets

Current Ratings

Admedus 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Admedus Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Admedus Limited, a healthcare company, develops, commercializes, and distributes next generation medical technologies and devices. The company was formerly known as Allied Healthcare Group Limited and changed its name to Admedus Limited in November 2013. Admedus operates under Biotechnology classification in USA and traded on OTC Market. more
NameAdmedus Limited
CEOLee RodneView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address301 Coronation Drive
ExchangeOTC Market
Phone61 8 9266 0100
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Portfolio Reporting

Admedus Corporate Directors

Michael Bennett Executive Director
William Rowley Non-Executive Director
Wayne Paterson Non-Executive Independent Director
Check also Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.